论文部分内容阅读
目的 :探讨宫颈腺癌的临床治疗效果。方法 :收集 1993年 9月～ 1999年 11月住院完成治疗的宫颈腺癌患者的临床资料 ,并对其进行回顾性分析。结果 :4 5例患者平均年龄 4 9 7岁 ,5年生存率为 5 5 75 % (2 5 /45 ) ,临床Ⅰb 期 6例 ,Ⅱ期 14例 ,Ⅲ期 19例 ,Ⅳ期 6例 ,其 5年生存率分别为 81 8%、 77 4 %、 4 6 7%和 0 0 %。结论 :宫颈腺癌的临床分期仍是影响其预后的主要因素
Objective: To investigate the clinical effect of cervical adenocarcinoma. Methods: The clinical data of patients with cervical adenocarcinoma who were hospitalized from September 1993 to November 1999 were collected and retrospectively analyzed. Results: The average age of 45 patients was 497 years. The 5-year survival rate was 5575% (2/45). There were 6 cases in stage Ⅰb, 14 cases in stage Ⅱ, 19 cases in stage Ⅲ, 6 cases in stage Ⅳ, The 5-year survival rates were 81.8%, 77.4%, 46.7% and 0% respectively. Conclusion: The clinical stage of cervical adenocarcinoma is still the main factor affecting its prognosis